Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis

There is a paucity of evidence surrounding the optimal antifungal therapy for use in chronic pulmonary aspergillosis (CPA) and the duration of therapy remains unclear. We retrospectively evaluated treatment outcomes, including change in quality of life scores (St George’s Respiratory Questionnaire (...

Descripción completa

Detalles Bibliográficos
Autores principales: Bongomin, Felix, Harris, Chris, Hayes, Gemma, Kosmidis, Chris, Denning, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892866/
https://www.ncbi.nlm.nih.gov/pubmed/29634721
http://dx.doi.org/10.1371/journal.pone.0193732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892866/
https://www.ncbi.nlm.nih.gov/pubmed/29634721
http://dx.doi.org/10.1371/journal.pone.0193732

Ejemplares similares